Back to Authors

Sloan, Jeff A.

https://orcid.org/0000-0002-3393-2387

Mayo Clinic

Mayo Clinic

Citations 224

Relationships among quality of life and survival in anemic patients with advanced cancer undergoing chemotherapy
Sloan, Jeff A. , Schaefer, Paul, Novotny, Paul J. , Silberstein, Peter T., Beardon, J. D., Allred, Jacob B., Mailliard, J A, Loprinzi, Charles L. , Witzig, Thomas E.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 6027-6027

10.1200/jco.2005.23.16_suppl.6027 Get It

Patient-reported fatigue and overall survival in locally advanced esophageal cancer: A Mayo Clinic Esophageal Adenocarcinoma and Barrett's Esophagus Registry Consortium study.
Romero, Yvonne , Kabat, Brian, Fredericksen, Mary, Deschamps, Claude, Jatoi, Aminah , Sloan, Jeff A. , Botros, M.E. , Stauder, Michael C. , Atherton, Philip J. , Miller, Robert C.

Journal of Clinical Oncology | February 23, 2017 | Volume: 29 | Issue: 4_suppl | Pages: 9-9

10.1200/jco.2011.29.4_suppl.9 Get It

9 Background: We examined patient-reported fatigue scores and overall survival (OS) in patients with esophageal cancer (EC) enrolled in the Mayo Clinic Esophageal Adenocarcinoma and Barrett's Esophagus Registry (EABE). Methods: 1,481 patients enrolled in the EABE between September 2001 and January 2009 returned a baseline quality of life questionnaire including a Linear Analog Self Assessment (LASA) fatigue score which was scored on a 0-10 scale, with 0 as the most extreme fatigue. Patients were categorized as having clinically deficient fatigue (DF) if they reported a score of ≤ 5 and clinically non-deficient fatigue (nDF) if they reported a score of > 5. Kaplan-Meier methodology and Cox models explored OS in relation to fatigue scores in patients with EC. Results: A total of 667 patients with EC were included in the EABE, of which 659 returned a registry questionnaire with a valid LASA fatigue score recorded. Median age at the time of registry entry was 65 years (range 23-92). A total of 392 (59%) and 267 patients (41%) reported DF and nDF, respectively. On univariate analysis, patients with nDF had improved 5-year survival compared to patients with DF. In patients having esophagectomy prior to LASA, those reporting nDF had improved survival compared to patients with DF. Similarly, in patients having no esophagectomy prior to LASA, those with nDF had improved survival compared to those with DF. Among the 368 patients with locally advanced EC (LAEC), those reporting nDF had improved 5-year overall survival compared to patients with DF (28% vs 17%, HR = 0.67, p = 0.003). This remained significant on multivariate analysis (HR = 0.71, p = 0.015). Conclusions: Patient-reported fatigue is associated with overall survival in patients with LAEC. As a result, fatigue scores should be considered as a stratification factor in future clinical trial design. [Table: see text] No significant financial relationships to disclose.
Phase III clinical trial evaluating low-molecular weight heparin (LMWH) in patients with advanced cancer: A North Central Cancer Treatment Group study
Schaefer, Paul, Okuno, Scott H. , Sloan, Jeff A. , Kutteh, Leila A., Fitch, Tom R., Dakhil, Shaker R. , Levitt, Ralph, Novotny, Paul J. , Loprinzi, Charles L. , Sideras, Kostandinos

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 8186-8186

10.1200/jco.2005.23.16_suppl.8186 Get It

Does participating in clinical trials change the experience of dying for patients with cancer?
Thompson, Carrie A. , Sloan, Jeff A. , Novotny, Paul J. , Tan, A., Loprinzi, Charles L. , Moynihan, Timothy J. , Shanafelt, Tait D.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 8066-8066

10.1200/jco.2005.23.16_suppl.8066 Get It

A pooled analysis to estimate the prevalence of sleep complaints among cancer patients
McMillan, D. E., Schaefer, Paul, Sloan, Jeff A. , Novotny, Paul J. , Huntington, Jefrey L., Beardon, J. D., Mailliard, J A, Loprinzi, Charles L. , Morgenthaler, Timothy I. , Yang, Ping

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 8053-8053

10.1200/jco.2005.23.16_suppl.8053 Get It

A phase III randomized trial of two different dosing schedules of erythropoietin (EPO) in patients with cancer-associated anemia: North Central Cancer Treatment Group (NCCTG) Study N02C2
Molina, R, Sloan, Jeff A. , Nikcevich, Daniel A., Schaefer, Paul, Rowland, Kendrith M. , Dentchev, Todor, Tschetter, Loren K., Novotny, P. J., Loprinzi, Charles L. , Steensma, David P.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 8031-8031

10.1200/jco.2005.23.16_suppl.8031 Get It

A phase III double blinded, placebo controlled, randomized trial of gabapentin in patients with chemotherapy-induced peripheral neuropathy: A North Central Cancer Treatment Group study
Wong, G, Michalak, J C, Sloan, Jeff A. , Mailliard, J A, Nikcevich, Daniel A., Novotny, Paul J. , Warner, Diana, Kutteh, Leila A., Dakhil, Shaker R. , Loprinzi, Charles L.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 8001-8001

10.1200/jco.2005.23.16_suppl.8001 Get It

Gemcitabine and epirubicin in patients with malignant pleural mesothelioma (MPM): A North Central Cancer Treatment Group phase II study
Okuno, Scott H. , Delaune, Robert, Sloan, Jeff A. , Aubry, Marie Christine, Foster, Nathan R. , Rowland, Kendrith M. , Mailliard, J A, Nikcevich, Daniel A., Jett, James R., Bot, Brian M.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 7264-7264

10.1200/jco.2005.23.16_suppl.7264 Get It

Burnout, career satisfaction, and well-being among US neurologists in 2016
Busis, Neil A. , Keran, Christopher M. , Levin, Kerry H., Schwarz, Heidi B., Molano, Jennifer Rose V. , Vidic, Thomas R., Kass, Joseph S. , Miyasaki, Janis M. , Sloan, Jeff A. , Cascino, Terrence L., Molano, Jennifer R, Shanafelt, Tait D. , Keran, Christopher M

Neurology | January 26, 2017 | Volume: 88 | Issue: 8 | Pages: 797-808

10.1212/wnl.0000000000003640 Get It

Quality of Life of Adults with Unhealed and Healed Diabetic Foot Ulcers
Trepman, Elly, Sloan, Jeff A. , Guse, Lorna , Strain, Laurel A., McIntyre, John S. , Embil, John M. , Goodridge, Donna M.

Foot & Ankle International | January 11, 2017 | Volume: 27 | Issue: 4 | Pages: 274-280

10.1177/107110070602700408 Get It

Background: Diabetic foot ulcers cause major treatment morbidity and cost of care. This study evaluated quality of life in patients with unhealed and healed diabetic foot ulcers. Methods: This was a cross-sectional study of adult diabetic patients (age 45 years or older) treated in a tertiary care foot clinic who had foot ulcers within the preceding 2 years. Patients with other diabetic complications or conditions that would potentially affect quality of life were excluded. Two patient groups of comparable age, gender distribution, and duration of diabetes were studied: 57 patients with unhealed ulcers (minimum duration, 6 months) and 47 patients with healed ulcers. Telephone interviews were done using the Short Form 12 (SF-12) (both groups) and a Cardiff Wound Impact Scale (CWIS) (unhealed ulcer group). Results: The mean SF-12 Physical Component Summary score was significantly lower for the group with unhealed ulcers (unhealed, 35 ± 8 points; healed, 39 ± 10 points; p = 0.04); these scores for both groups were significantly lower than published Short Form 36 (SF-36) scores for general, diabetic, and hypertensive populations. The mean SF-12 Mental Component Summary scores of the groups did not differ significantly from each other or from published population scores. CWIS responses showed that patients with unhealed ulcers were frustrated with healing and had anxiety about the wounds, resulting in marked negative impact on the average Well-being Component Score (35 ± 6 points). Conclusions: Individuals with diabetic foot ulcers experience profound compromise of physical quality of life, which is worse in those with unhealed ulcers.